|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61P 1/04 | (2006.01) | ||
| A61P 17/00 | (2006.01) |
| (11) | Number of the document | 3524230 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18213458.5 |
| Date of filing the European patent application | 2013-04-02 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 12163078 | 2012-04-04 | EP |
| (72) |
FETSCHER, Alfred , DE
SCHER, Jochen Matthias , DE
|
| (73) |
Alkahest, Inc. ,
125 Shoreway Road, Suite D, San Carlos, CA 94070,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS |
| PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS |